Radiation-Sensitizing Agents

"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.

Descriptor ID	D011838
MeSH Number(s)	D27.505.954.600
Concept/Terms	Radiation-Sensitizing Agents Radiation-Sensitizing Agents Radiation Sensitizers Sensitizers, Radiation Radiation Sensitizing Agents Sensitizing Agents, Radiation Radiosensitizing Agents Agents, Radiosensitizing Radiosensitizing Drugs Drugs, Radiosensitizing Agents, Radiation-Sensitizing Agents, Radiation Sensitizing Radiation-Sensitizing Drugs Drugs, Radiation-Sensitizing Radiation Sensitizing Drugs Radiation-Sensitizing Effect Radiation-Sensitizing Effect Effect, Radiation-Sensitizing Radiation Sensitizing Effect Radiosensitizing Effect Effect, Radiosensitizing Radiosensitizing Effects Effects, Radiosensitizing Radiation-Sensitizing Effects Effects, Radiation-Sensitizing Radiation Sensitizing Effects

Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Radiation-Sensitizing Agents [D27.505.954.600]

Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".

Radiation-Sensitizing Agents
Photosensitizing Agents

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in this website by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publications.

Bar chart showing 13 publications over 13 distinct years, with a maximum of 1 publications in 1996 and 1997 and 1998 and 1999 and 2000 and 2002 and 2004 and 2005 and 2011 and 2012 and 2016 and 2023 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1998	0	1	1
1999	1	0	1
2000	1	0	1
2002	1	0	1
2004	1	0	1
2005	1	0	1
2011	1	0	1
2012	1	0	1
2016	1	0	1
2023	1	0	1
2024	0	1	1

Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.

Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 Dec; 42(34):4095-4102.

View in: PubMed
Winuprasith T, Koirala P, McClements DJ, Khomein P. Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents. Int J Nanomedicine. 2023; 18:4449-4470.

View in: PubMed
Hartford AC, Davis TH, Buckey JC, Foote RL, Sinesi MS, Williams BB, Fariss AK, Schaner PE, Claus PL, Okuno SH, Hussey JR, Clarke RE. Hyperbaric Oxygen as Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx: A Phase 1 Dose-Escalation Study. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):481-486.

View in: PubMed
Fu S, Yang Y, Das TK, Tirtha D, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. ?-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. PLoS One. 2012; 7(6):e38465.

View in: PubMed
Hunter KU, Feng FY, Griffith KA, Francis IR, Lawrence TS, Desai S, Murphy JD, Zalupski MM, Ben-Josef E. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):921-6.

View in: PubMed
Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):25-36.

View in: PubMed
Cecchini S, Girouard S, Huels MA, Sanche L, Hunting DJ. Interstrand cross-links: a new type of gamma-ray damage in bromodeoxyuridine-substituted DNA. Biochemistry. 2005 Feb 15; 44(6):1932-40.

View in: PubMed
Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK. CpG oligodeoxynucleotide enhances tumor response to radiation. Cancer Res. 2004 Aug 01; 64(15):5074-7.

View in: PubMed
Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):23-8.

View in: PubMed
Safran H, Wanebo HJ, Hesketh PJ, Akerman P, Ianitti D, Cioffi W, DiPetrillo T, Wolf B, Koness J, McAnaw R, Moore T, Chen MH, Radie-Keane K. Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):889-94.

View in: PubMed

People

Explore

Similar Concepts

Top Journals